Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL

Blood. 2020 Jan 30;135(5):387-391. doi: 10.1182/blood.2019003293.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antigens, CD19 / metabolism*
  • Child
  • Child, Preschool
  • Humans
  • Immunotherapy, Adoptive*
  • Infant
  • Infant, Newborn
  • Leukemia, Prolymphocytic, B-Cell / immunology*
  • Leukemia, Prolymphocytic, B-Cell / therapy*
  • Neoplasm Recurrence, Local / immunology*
  • Neoplasm Recurrence, Local / therapy*
  • Receptors, Chimeric Antigen / immunology*
  • Remission Induction
  • Treatment Outcome

Substances

  • Antigens, CD19
  • Receptors, Chimeric Antigen